Papers
2
Total Citations
32
H-Index
2
About
Joe Flanagan is a leading surgical oncologist whose research centers on minimally invasive liver resection (MILR) for colorectal liver metastases (CRLM). His major contributions include co-authoring the landmark SIMMILR-CRLM study (2022, 20 citations), a retrospective international multicentric cohort from six centers that compared open, laparoscopic, and robotic approaches for CRLM. This work demonstrated the safety and feasibility of MILR, challenging traditional open surgery as the gold standard. Flanagan further advanced the field with the SIMMILR-2 survival study (2022, 12 citations), which used propensity score matching to evaluate long-term outcomes in patients meeting Milan criteria, providing critical evidence that minimally invasive techniques do not compromise oncologic survival. His research has directly shaped clinical guidelines for liver metastasis management, emphasizing reduced morbidity without sacrificing efficacy. By coordinating a global network of centers, Flanagan has built a robust evidence base for MILR, earning recognition as a pioneer in hepatobiliary surgery. With over 30 combined citations from these foundational studies, his work continues to influence surgical practice and inspire future investigations into optimizing patient outcomes through less invasive approaches.
Research Focus
Key Achievements
Top Papers
- 1
- 2